Article Information
History
- October 18, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Linda Wang, B.S., M.P.H.1,
- Neeraj Javadekar1,
- Ananya Rajagopalan1,
- Nichole M. Rogovoy, B.S.1,
- Kazi T. Haq, Ph.D.1,
- Craig S. Broberg, M.D.1 and
- Larisa G. Tereshchenko, M.D., Ph.D.1,*
- ↵*Correspondence: Larisa Tereshchenko, 3181 SW Sam Jackson Park Rd; UHN62; Portland OR, 97239. E-mail:tereshch{at}ohsu.edu. Phone:503-494-7400; Fax:503-494-8550.
Posted October 18, 2019.
Eligibility for Subcutaneous Implantable Cardioverter Defibrillator in Congenital Heart Disease
